Your browser is no longer supported. Please, upgrade your browser.
AnPac Bio-Medical Science Co., Ltd.
Index- P/E- EPS (ttm)- Insider Own37.84% Shs Outstand10.95M Perf Week1.59%
Market Cap63.89M Forward P/E- EPS next Y-0.58 Insider Trans0.00% Shs Float1.33M Perf Month-6.21%
Income- PEG- EPS next Q-0.16 Inst Own0.63% Short Float0.72% Perf Quarter63.07%
Sales- P/S- EPS this Y-140.30% Inst Trans- Short Ratio0.01 Perf Half Y-0.17%
Book/sh0.34 P/B16.88 EPS next Y41.40% ROA- Target Price- Perf Year-
Cash/sh0.13 P/C42.59 EPS next 5Y- ROE- 52W Range3.15 - 12.18 Perf YTD8.30%
Dividend- P/FCF- EPS past 5Y- ROI-392.20% 52W High-52.87% Beta-
Dividend %- Quick Ratio0.90 Sales past 5Y- Gross Margin- 52W Low82.22% ATR0.44
Employees101 Current Ratio0.90 Sales Q/Q-37.90% Oper. Margin- RSI (14)55.95 Volatility4.42% 6.11%
OptionableNo Debt/Eq0.24 EPS Q/Q-83.20% Profit Margin- Rel Volume0.02 Prev Close5.71
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume1.59M Price5.74
Recom2.00 SMA202.10% SMA5017.97% SMA200-1.01% Volume24,725 Change0.53%
Dec-15-20 07:45AM  
Dec-14-20 07:30AM  
Dec-10-20 11:01PM  
Dec-04-20 04:01PM  
Nov-25-20 11:01AM  
Nov-16-20 04:01PM  
Nov-10-20 07:30AM  
Nov-02-20 07:30AM  
Oct-26-20 06:45AM  
Oct-13-20 05:00AM  
Oct-07-20 07:00AM  
Oct-01-20 07:30AM  
Sep-23-20 08:15AM  
Sep-15-20 07:00AM  
Sep-11-20 08:05AM  
Sep-10-20 06:53AM  
Sep-08-20 10:04AM  
Sep-04-20 07:30AM  
Aug-28-20 08:00AM  
Aug-24-20 07:30AM  
Aug-11-20 07:30AM  
Aug-07-20 07:30AM  
Aug-04-20 07:30AM  
Jul-29-20 08:26AM  
Jul-13-20 08:40AM  
Jun-26-20 08:00AM  
Jun-22-20 08:46AM  
Jun-19-20 08:46AM  
Jun-10-20 04:20PM  
Jun-03-20 07:39AM  
Jun-02-20 05:00PM  
May-26-20 08:00AM  
May-18-20 08:30AM  
May-11-20 06:46AM  
Apr-30-20 09:15AM  
Mar-30-20 08:30AM  
Mar-27-20 08:00AM  
Mar-24-20 07:30AM  
Mar-03-20 08:30AM  
Feb-27-20 09:00AM  
Feb-06-20 08:15AM  
Feb-03-20 09:17AM  
Jan-30-20 02:09PM  
Anpac Bio-Medical Science Co., Ltd., a development-stage biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China and the United States. It also manufactures cancer differentiation analysis devices; and offers physical checkup package services. The company was founded in 2010 and is headquartered in Lishui, the People's Republic of China.